Lyell Immunopharma, Inc.
LYEL
$13.22
$0.524.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.66% | -33.28% | -27.45% | -43.64% | -42.77% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 65.99% | 51.31% | -9.70% | -37.69% | 1.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.54% | -31.26% | -27.07% | -43.54% | -42.12% |
|
|
|||||
| Total Current Assets | -13.54% | -31.26% | -27.07% | -43.54% | -42.12% |
| Net Property, Plant & Equipment | -25.41% | -26.46% | -54.59% | -54.08% | -50.37% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 39.01% | 2.52% | -22.79% | -9.10% | 8.44% |
| Total Assets | -18.42% | -30.72% | -34.12% | -41.08% | -38.09% |
|
|
|||||
| Total Accounts Payable | 46.67% | -46.09% | -28.59% | -19.53% | -23.84% |
| Total Accrued Expenses | -7.48% | -28.69% | -6.19% | 3.82% | 25.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.67% | 13.78% | 23.18% | 23.37% | 23.56% |
| Total Finance Division Other Current Liabilities | -85.91% | 48.94% | -- | 447.03% | 151.14% |
| Total Other Current Liabilities | -85.91% | 48.94% | -- | 447.03% | 151.14% |
| Total Current Liabilities | -10.51% | -8.14% | -4.88% | 19.51% | 27.61% |
|
|
|||||
| Total Current Liabilities | -10.51% | -8.14% | -4.88% | 19.51% | 27.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.17% | -17.79% | -13.91% | -12.61% | -11.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -83.22% | -84.11% | -24.80% | -11.89% | -11.55% |
| Total Liabilities | -17.49% | -14.98% | -10.93% | -1.27% | 2.43% |
|
|
|||||
| Common Stock & APIC | 10.60% | 8.10% | 7.41% | 3.78% | 4.04% |
| Retained Earnings | -17.63% | -20.40% | -28.24% | -29.89% | -31.48% |
| Treasury Stock & Other | -105.70% | -16.84% | -73.55% | 114.36% | 139.11% |
| Total Common Equity | -18.68% | -35.17% | -37.98% | -47.23% | -44.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.68% | -35.17% | -37.98% | -47.23% | -44.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.68% | -35.17% | -37.98% | -47.23% | -44.21% |
|
|
|||||